You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 10, Issue 4

April 2018 - 42 articles

Cover Story: Anaplastic large cell lymphoma (ALCL) is a T-cell neoplasm with unique morphology and phenotype, which is subdivided into four different entities depending on clinical and molecular features: systemic ALK-positive ALCL, systemic ALK-negative ALCL, primary cutaneous ALCL, and breast implant-associated ALCL. While ALK fusion proteins are the genetic hallmark of ALK-positive ALCL and present a paradigm of a dominant oncogenic driver mutation, the genetic landscape of ALK-negative ALCL has only recently been explored further, deepening our understanding of its clinical behavior and pathogenesis and providing new targets to develop specific therapies. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (42)

  • Article
  • Open Access
29 Citations
9,977 Views
11 Pages

Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines

  • Ryohei Kozaki,
  • Meike Vogler,
  • Harriet S. Walter,
  • Sandrine Jayne,
  • David Dinsdale,
  • Reiner Siebert,
  • Martin J.S. Dyer and
  • Toshio Yoshizawa

23 April 2018

Bruton’s tyrosine kinase (BTK) is a key regulator of the B-cell receptor signaling pathway, and aberrant B-cell receptor (BCR) signaling has been implicated in the survival of malignant B-cells. However, responses of the diffuse large B-cell lymphoma...

  • Brief Report
  • Open Access
6 Citations
5,241 Views
13 Pages

Selective Inhibition of Histone Deacetylation in Melanoma Increases Targeted Gene Delivery by a Bacteriophage Viral Vector

  • Samuel Campbell,
  • Keittisak Suwan,
  • Sajee Waramit,
  • Eric Ofori Aboagye and
  • Amin Hajitou

21 April 2018

The previously developed adeno-associated virus/phage (AAVP) vector, a hybrid between M13 bacteriophage (phage) viruses that infect bacteria only and human Adeno-Associated Virus (AAV), is a promising tool in targeted gene therapy against cancer. AAV...

  • Article
  • Open Access
52 Citations
8,537 Views
15 Pages

Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress

  • Christophe Deben,
  • Vanessa Deschoolmeester,
  • Jorrit De Waele,
  • Julie Jacobs,
  • Jolien Van den Bossche,
  • An Wouters,
  • Marc Peeters,
  • Christian Rolfo,
  • Evelien Smits and
  • Filip Lardon
  • + 1 author

21 April 2018

The compound APR-246 (PRIMA-1MET) is a known reactivator of (mutant) p53 and inducer of oxidative stress which can sensitize cancer cells to platinum-based chemotherapeutics. However, the effect of a hypoxic tumor environment has been largely overloo...

  • Review
  • Open Access
45 Citations
8,208 Views
19 Pages

Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms

  • Shyambabu Chaurasiya,
  • Nanhai G. Chen and
  • Susanne G. Warner

19 April 2018

A growing body of evidence suggests that a subset of cells within tumors are resistant to conventional treatment modalities and may be responsible for disease recurrence. These cells are called cancer stem cells (CSC), which share properties with nor...

  • Review
  • Open Access
65 Citations
9,336 Views
29 Pages

Innovative Diagnostic Methods for Early Prostate Cancer Detection through Urine Analysis: A Review

  • Carmen Bax,
  • Gianluigi Taverna,
  • Lidia Eusebio,
  • Selena Sironi,
  • Fabio Grizzi,
  • Giorgio Guazzoni and
  • Laura Capelli

18 April 2018

Prostate cancer is the second most common cause of cancer death among men. It is an asymptomatic and slow growing tumour, which starts occurring in young men, but can be detected only around the age of 40–50. Although its long latency period an...

  • Perspective
  • Open Access
19 Citations
7,090 Views
5 Pages

Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells

  • Chung-Chun Wu,
  • Chih-Yeu Fang,
  • Sheng-Yen Huang,
  • Shih-Hsin Chiu,
  • Chia-Huei Lee and
  • Jen-Yang Chen

17 April 2018

Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma derived from the epithelium of the post-nasal cavity, with a unique geographic and ethnic distribution. Epstein–Barr virus (EBV) is an etiological agent of NPC, but how it contributes...

  • Review
  • Open Access
20 Citations
6,504 Views
21 Pages

17 April 2018

The Hippo pathway serves as a key barrier for oncogenic transformation. It acts by limiting the activity of the proto-oncogenes YAP and TAZ. Reduced Hippo signaling and elevated YAP/TAZ activities are frequently observed in various types of tumors. E...

  • Feature Paper
  • Commentary
  • Open Access
11 Citations
6,770 Views
10 Pages

17 April 2018

The vertebrate body shape is formed by the specific sizes and shapes of its resident tissues and organs, whose alignments are essential for proper functioning. To maintain tissue and organ shape, and thereby function, it is necessary to remove senesc...

  • Article
  • Open Access
14 Citations
7,051 Views
14 Pages

NF-κB Signaling Regulates Epstein–Barr Virus BamHI-Q-Driven EBNA1 Expression

  • Rob J. A. Verhoeven,
  • Shuang Tong,
  • Jingfeng Zong,
  • Yixin Chen,
  • Sai-Wah Tsao,
  • Jianji Pan and
  • Honglin Chen

16 April 2018

Epstein–Barr virus (EBV) nuclear antigen 1 (EBNA1) is one of the few viral proteins expressed by EBV in nasopharyngeal carcinoma (NPC), most likely because of its essential role in maintaining the viral genome in EBV-infected cells. In NPC, EBNA1 exp...

  • Commentary
  • Open Access
155 Citations
13,879 Views
11 Pages

15 April 2018

Tumors and tumor-derived cell lines contain polyploid giant cells with significantly elevated genomic content, often with multiple nuclei. The frequency of giant cells can increase markedly following anticancer treatment. Although giant cells enter a...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694